42.39
6.59%
+2.62
시간 외 거래:
41.6073
-0.7827
-1.85%
전일 마감가:
$39.77
열려 있는:
$39.99
하루 거래량:
779.16K
시가총액:
$445.40M
수익:
$1.54M
순이익/손실:
$-44.60M
주가수익비율:
-3.8536
EPS:
-11
순현금흐름:
$-36.10M
1주 성능:
+13.80%
1개월 성능:
+6.08%
6개월 성능:
+1,010%
1년 성능:
+318.46%
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617 963 0100
주소
500 River Ridge Drive, Norwood, MA
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
2020-07-07 | 개시 | ROTH Capital | Buy |
2020-06-17 | 개시 | BTIG Research | Buy |
2020-03-26 | 개시 | Nomura | Buy |
2019-04-05 | 개시 | Jefferies | Buy |
2019-03-20 | 개시 | Oppenheimer | Outperform |
2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
2018-12-26 | 개시 | H.C. Wainwright | Buy |
2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
2018-10-24 | 개시 | B. Riley FBR | Buy |
2018-01-19 | 개시 | Raymond James | Outperform |
2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
2017-11-08 | 재확인 | Noble Financial | Buy |
2017-09-29 | 재개 | Noble Financial | Buy |
2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire Inc.
Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength
Zacks Investment Research
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
Zacks Investment Research
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire Inc.
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire Inc.
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
Corbus Pharmaceuticals Holdings Inc (CRBP) 매출 2024
CRBP은 2021-09-30 종료 분기에 대해 매출(지난 12개월)이 1.54M 달러로 보고했습니다.
Corbus Pharmaceuticals Holdings Inc (CRBP) 순이익 2024
CRBP은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -44.60M 달러로 보고했으며, 전년대비 -5.33% 감소했습니다.
Corbus Pharmaceuticals Holdings Inc (CRBP) 현금흐름 2024
2023-12-31 종료 분기에 CRBP은 현금흐름(지난 12개월)으로 -36.10M 달러를 기록했으며, 전년 대비 +3.88% 증가했습니다.
Corbus Pharmaceuticals Holdings Inc (CRBP) 주당 순이익 2024
CRBP이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -10.35달러이며, 전년 대비 -1.87% 감소했습니다.
자본화:
|
볼륨(24시간):